作者: Namdeo Prabhu , Sanjay S. Rao , S. M. Kotrashetti , Shridhar D. Baliga , Seema R. Hallikerimath
DOI: 10.1007/S12663-013-0580-X
关键词: Pathology 、 Oral and maxillofacial surgery 、 Effective treatment 、 Randomized controlled trial 、 Medicine 、 Oral submucous fibrosis 、 Otorhinolaryngology 、 In patient 、 Pentoxifylline 、 Internal medicine 、 Disease
摘要: Background and Aim As far as research regarding any disease is concerned, each every aspect poses a challenge. One such entity that challenge in our arena oral submucous fibrosis (OSF) no effective treatment available for this progressively disabling condition with high malignant potential. Hence the present study was undertaken aim to determine use of pentoxifylline (PTX) on clinical histopathologic course OSF.